Select features to define your cohort
| Patient ID | Age at Diagnosis | Sex | Race | Definition | Menopausal Status | Cancer Type | ER | PR | HER2 | Event | Event Site | Survival Status | Survival Time (years) | Subtype | Genetic Ancestry | hidden |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TCGA-A7-A13G | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | new primary | skin | alive | 1.97 | LumA | European | TCGA.A7.A13G.01A.11R.A13Q.07 |
| TCGA-A7-A13G | 79 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | negative | new primary | skin | alive | 1.97 | LumA | European | TCGA.A7.A13G.11A.51R.A13Q.07 |
| TCGA-E2-A10B | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | new primary | lung | alive | 2.05 | LumA | European | TCGA.E2.A10B.01A.11R.A10J.07 |
| TCGA-E2-A14R | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | new primary | endometrial | alive | 2.31 | Basal | European | TCGA.E2.A14R.01A.11R.A115.07 |
| TCGA-A7-A13H | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | new primary | skin | alive | 2.46 | NA | European | TCGA.A7.A13H.01A.11R.A22K.07 |
| TCGA-AR-A5QM | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | new primary | melanoma | alive | 6.11 | LumA | European | TCGA.AR.A5QM.01A.11R.A27Q.07 |
| TCGA-B6-A2IU | 62 | female | White | Primary solid Tumor | indeterminate | ILC | positive | positive | not evaluated | new primary | lung | alive | 14.17 | LumA | European | TCGA.B6.A2IU.01A.32R.A18M.07 |
| TCGA-B6-A0WZ | 50 | female | Black or African American | Primary solid Tumor | indeterminate | IDC | positive | positive | not evaluated | new primary | bone | alive | 17.23 | LumA | African_admix | TCGA.B6.A0WZ.01A.11R.A109.07 |
| TCGA-BH-A18V | 48 | female | White | Primary solid Tumor | not available | IDC | negative | negative | negative | metastasis | intramammary node | dead | 4.26 | Basal | European | TCGA.BH.A18V.01A.11R.A12D.07 |
| TCGA-BH-A18V | 48 | female | White | Solid Tissue Normal | not available | IDC | negative | negative | negative | metastasis | intramammary node | dead | 4.26 | Basal | European | TCGA.BH.A18V.11A.52R.A12D.07 |
| TCGA-E9-A1NI | 51 | female | White | Primary solid Tumor | postmenopausal | IDC/ILC | positive | positive | negative | NA | NA | alive | NA | NA | European | TCGA.E9.A1NI.01A.11R.A14D.07 |
| TCGA-PL-A8LV | 54 | female | Black or African American | Primary solid Tumor | unknown | medullary carcinoma | not evaluated | not evaluated | not evaluated | NA | NA | alive | NA | Basal | African | TCGA.PL.A8LV.01A.21R.A41B.07 |
| TCGA-A2-A25D | 90 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | NA | LumA | European | TCGA.A2.A25D.01A.12R.A16F.07 |
| TCGA-A8-A06N | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | NA | LumB | European | TCGA.A8.A06N.01A.11R.A00Z.07 |
| TCGA-A8-A081 | 80 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | LumB | European | TCGA.A8.A081.01A.11R.A00Z.07 |
| TCGA-A8-A083 | 67 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | LumA | European | TCGA.A8.A083.01A.21R.A00Z.07 |
| TCGA-A8-A08H | 66 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | Normal | European | TCGA.A8.A08H.01A.21R.A00Z.07 |
| TCGA-A8-A090 | 74 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | LumA | European | TCGA.A8.A090.01A.11R.A00Z.07 |
| TCGA-A8-A094 | 75 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | NA | Her2 | European | TCGA.A8.A094.01A.11R.A00Z.07 |
| TCGA-A8-A096 | 73 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | NA | LumB | European | TCGA.A8.A096.01A.11R.A00Z.07 |
| TCGA-A8-A09G | 79 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | NA | Her2 | European | TCGA.A8.A09G.01A.21R.A00Z.07 |
| TCGA-A8-A09Z | 83 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | negative | negative | NA | NA | alive | NA | LumB | European | TCGA.A8.A09Z.01A.11R.A00Z.07 |
| TCGA-AC-A3W6 | 90 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | NA | NA | European | TCGA.AC.A3W6.01A.12R.A22K.07 |
| TCGA-C8-A12K | 80 | female | Asian | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | NA | Basal | East Asian | TCGA.C8.A12K.01A.21R.A115.07 |
| TCGA-C8-A12T | 43 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | NA | Her2 | East Asian | TCGA.C8.A12T.01A.11R.A115.07 |
| TCGA-C8-A133 | 65 | female | White | Primary solid Tumor | postmenopausal | ductal/mucinous | positive | positive | not evaluated | NA | NA | alive | NA | NA | South Asian_admix | TCGA.C8.A133.01A.32R.A12D.07 |
| TCGA-C8-A26Y | 90 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | NA | Her2 | East Asian | TCGA.C8.A26Y.01A.11R.A16F.07 |
| TCGA-D8-A1JK | 90 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | NA | Basal | European | TCGA.D8.A1JK.01A.11R.A13Q.07 |
| TCGA-LL-A6FP | 90 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | NA | LumA | European | TCGA.LL.A6FP.01A.11R.A31O.07 |
| TCGA-AC-A7VC | 56 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | NA | Basal | European | TCGA.AC.A7VC.01A.11R.A352.07 |
| TCGA-C8-A275 | 56 | female | Asian | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | NA | Her2 | East Asian | TCGA.C8.A275.01A.21R.A16F.07 |
| TCGA-AN-A0AM | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.01 | LumB | European | TCGA.AN.A0AM.01A.11R.A034.07 |
| TCGA-C8-A1HJ | 53 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.01 | Basal | East Asian | TCGA.C8.A1HJ.01A.11R.A13Q.07 |
| TCGA-E9-A1N4 | 41 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 0.01 | NA | European | TCGA.E9.A1N4.01A.11R.A14M.07 |
| TCGA-E9-A1N4 | 41 | female | White | Solid Tissue Normal | premenopausal | IDC/ILC | positive | positive | positive | NA | NA | alive | 0.01 | NA | European | TCGA.E9.A1N4.11A.33R.A14M.07 |
| TCGA-PL-A8LX | 35 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | metastasis | bone|liver | alive | 0.01 | LumA | African | TCGA.PL.A8LX.01A.11R.A41B.07 |
| TCGA-C8-A273 | 29 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | LumA | East Asian | TCGA.C8.A273.01A.11R.A16F.07 |
| TCGA-AN-A041 | 29 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.02 | LumA | European_admix | TCGA.AN.A041.01A.11R.A034.07 |
| TCGA-C8-A12W | 49 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | LumB | East Asian | TCGA.C8.A12W.01A.11R.A115.07 |
| TCGA-C8-A138 | 54 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 0.02 | Her2 | East Asian | TCGA.C8.A138.01A.11R.A115.07 |
| TCGA-C8-A1HK | 53 | female | Asian | Primary solid Tumor | perimenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.02 | Her2 | East Asian | TCGA.C8.A1HK.01A.21R.A13Q.07 |
| TCGA-C8-A26W | 58 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.02 | LumB | East Asian | TCGA.C8.A26W.01A.11R.A16F.07 |
| TCGA-C8-A3M8 | 68 | female | Asian | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.02 | LumB | East Asian | TCGA.C8.A3M8.01A.11R.A213.07 |
| TCGA-AR-A0U0 | 73 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | not evaluated | NA | NA | alive | 0.02 | Basal | European | TCGA.AR.A0U0.01A.11R.A109.07 |
| TCGA-C8-A8HP | 59 | female | Asian | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | positive | NA | NA | alive | 0.02 | Her2 | East Asian | TCGA.C8.A8HP.01A.11R.A36F.07 |
| TCGA-E9-A5FL | 65 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | 0.02 | Basal | European | TCGA.E9.A5FL.01A.11R.A27Q.07 |
| TCGA-PL-A8LY | 30 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.02 | Normal | African | TCGA.PL.A8LY.01A.11R.A41B.07 |
| TCGA-AC-A5XU | 74 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 0.02 | LumA | African | TCGA.AC.A5XU.01A.11R.A28M.07 |
| TCGA-AN-A0XP | 69 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.02 | LumA | European | TCGA.AN.A0XP.01A.11R.A109.07 |
| TCGA-C8-A26V | 47 | female | Asian | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.02 | LumB | East Asian | TCGA.C8.A26V.01A.11R.A16F.07 |
| TCGA-C8-A278 | 61 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.02 | Her2 | East Asian | TCGA.C8.A278.01A.11R.A169.07 |
| TCGA-C8-A8HQ | 53 | female | Asian | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.02 | NA | East Asian | TCGA.C8.A8HQ.01A.11R.A36F.07 |
| TCGA-AN-A03X | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A03X.01A.21R.A00Z.07 |
| TCGA-AN-A03Y | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | LumB | European | TCGA.AN.A03Y.01A.21R.A00Z.07 |
| TCGA-AN-A046 | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A046.01A.21R.A034.07 |
| TCGA-AN-A0AR | 55 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | Basal | European | TCGA.AN.A0AR.01A.11R.A00Z.07 |
| TCGA-AN-A0AS | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0AS.01A.11R.A00Z.07 |
| TCGA-AN-A0AT | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | Basal | European | TCGA.AN.A0AT.01A.11R.A034.07 |
| TCGA-AN-A0FV | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.03 | Her2 | European | TCGA.AN.A0FV.01A.11R.A00Z.07 |
| TCGA-AN-A0FX | 52 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.03 | Basal | European | TCGA.AN.A0FX.01A.11R.A034.07 |
| TCGA-AN-A0FY | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.03 | LumB | European | TCGA.AN.A0FY.01A.11R.A034.07 |
| TCGA-AN-A0FZ | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0FZ.01A.11R.A034.07 |
| TCGA-AN-A0XN | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0XN.01A.21R.A109.07 |
| TCGA-AN-A0XR | 55 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | LumB | European | TCGA.AN.A0XR.01A.11R.A109.07 |
| TCGA-AN-A0XS | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | positive | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0XS.01A.22R.A109.07 |
| TCGA-AN-A0XT | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0XT.01A.11R.A109.07 |
| TCGA-AN-A0XU | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.03 | Basal | European | TCGA.AN.A0XU.01A.11R.A109.07 |
| TCGA-AN-A0FW | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | Indeterminate | negative | NA | NA | alive | 0.03 | LumA | European | TCGA.AN.A0FW.01A.11R.A034.07 |
| TCGA-E2-A1IL | 78 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.04 | LumA | European | TCGA.E2.A1IL.01A.11R.A14D.07 |
| TCGA-AN-A0G0 | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.04 | NA | European | TCGA.AN.A0G0.01A.11R.A034.07 |
| TCGA-AN-A049 | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.05 | LumA | European | TCGA.AN.A049.01A.21R.A00Z.07 |
| TCGA-E9-A1R2 | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | equivocal | NA | NA | alive | 0.05 | LumA | European | TCGA.E9.A1R2.01A.11R.A14D.07 |
| TCGA-E9-A1RD | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.05 | LumA | European | TCGA.E9.A1RD.01A.11R.A157.07 |
| TCGA-E9-A1RD | 67 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.05 | LumA | European | TCGA.E9.A1RD.11A.33R.A157.07 |
| TCGA-E9-A244 | 54 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.06 | Basal | European | TCGA.E9.A244.01A.11R.A169.07 |
| TCGA-E9-A227 | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.07 | LumA | European | TCGA.E9.A227.01A.11R.A157.07 |
| TCGA-D8-A27R | 41 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.08 | LumB | European | TCGA.D8.A27R.01A.11R.A16F.07 |
| TCGA-E9-A1R4 | 66 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.08 | LumB | European | TCGA.E9.A1R4.01A.21R.A14D.07 |
| TCGA-E9-A249 | 45 | female | White | Primary solid Tumor | premenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.08 | LumB | European | TCGA.E9.A249.01A.11R.A169.07 |
| TCGA-A8-A08A | 89 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | LumA | European | TCGA.A8.A08A.01A.11R.A32Y.07 |
| TCGA-A8-A09W | 70 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A09W.01A.11R.A00Z.07 |
| TCGA-A8-A0A7 | 57 | female | not available | Primary solid Tumor | postmenopausal | ILC | negative | negative | positive | NA | NA | alive | 0.08 | Her2 | European | TCGA.A8.A0A7.01A.11R.A00Z.07 |
| TCGA-A8-A06Q | 63 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A06Q.01A.11R.A034.07 |
| TCGA-A8-A06Z | 84 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A06Z.01A.11R.A00Z.07 |
| TCGA-A8-A09C | 69 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A09C.01A.11R.A00Z.07 |
| TCGA-A8-A09N | 57 | female | not available | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.08 | LumB | European | TCGA.A8.A09N.01A.11R.A00Z.07 |
| TCGA-AC-A2QH | 58 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | negative | negative | NA | NA | alive | 0.08 | Basal | European | TCGA.AC.A2QH.01A.11R.A18M.07 |
| TCGA-AC-A8OQ | 72 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | Indeterminate | NA | NA | alive | 0.09 | Basal | African_admix | TCGA.AC.A8OQ.01A.11R.A41B.07 |
| TCGA-E2-A15K | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.09 | LumB | European | TCGA.E2.A15K.01A.11R.A12P.07 |
| TCGA-E2-A15K | 58 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.09 | LumB | European | TCGA.E2.A15K.11A.13R.A12P.07 |
| TCGA-E9-A1RF | 68 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.1 | LumA | European | TCGA.E9.A1RF.01A.11R.A157.07 |
| TCGA-E9-A1RF | 68 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.1 | LumA | European | TCGA.E9.A1RF.11A.32R.A157.07 |
| TCGA-AC-A8OR | 75 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.11 | NA | European | TCGA.AC.A8OR.01A.21R.A41B.07 |
| TCGA-E2-A15H | 38 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.11 | LumA | European | TCGA.E2.A15H.01A.11R.A12D.07 |
| TCGA-E9-A1R5 | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.11 | LumA | European | TCGA.E9.A1R5.01A.11R.A14M.07 |
| TCGA-E9-A243 | 52 | female | White | Primary solid Tumor | perimenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.12 | Basal | European | TCGA.E9.A243.01A.21R.A169.07 |
| TCGA-AC-A2FB | 65 | female | White | Primary solid Tumor | not available | ILC | positive | positive | positive | NA | NA | alive | 0.12 | LumA | European | TCGA.AC.A2FB.01A.11R.A17B.07 |
| TCGA-AC-A2FB | 65 | female | White | Solid Tissue Normal | not available | ILC | positive | positive | positive | NA | NA | alive | 0.12 | LumA | European | TCGA.AC.A2FB.11A.13R.A17B.07 |
| TCGA-E9-A1RI | 43 | female | White | Primary solid Tumor | premenopausal | IDC/ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.13 | NA | European | TCGA.E9.A1RI.01A.11R.A169.07 |
| TCGA-E9-A1RI | 43 | female | White | Solid Tissue Normal | premenopausal | IDC/ILC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.13 | NA | European | TCGA.E9.A1RI.11A.41R.A169.07 |
| TCGA-D8-A145 | 80 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.13 | LumA | European | TCGA.D8.A145.01A.11R.A115.07 |
| TCGA-D8-A27P | 64 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.13 | LumA | European | TCGA.D8.A27P.01A.11R.A16F.07 |
| TCGA-D8-A1XS | 48 | male | White | Primary solid Tumor | not applicable | ductal/micropapillary | positive | positive | positive | NA | NA | alive | 0.14 | NA | European | TCGA.D8.A1XS.01A.11R.A14M.07 |
| TCGA-AC-A6NO | 43 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | positive | negative | NA | NA | alive | 0.14 | LumA | African_admix | TCGA.AC.A6NO.01A.12R.A33J.07 |
| TCGA-AN-A04D | 58 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.14 | Basal | European | TCGA.AN.A04D.01A.21R.A034.07 |
| TCGA-A7-A3RF | 79 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | metastasis | bone>liver | alive | 0.15 | NA | European | TCGA.A7.A3RF.01A.11R.A22K.07 |
| TCGA-AN-A04C | 51 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.15 | Her2 | European | TCGA.AN.A04C.01A.21R.A034.07 |
| TCGA-AC-A3W5 | 65 | female | Black or African American | Primary solid Tumor | not evaluated | ILC | positive | positive | not evaluated | NA | NA | alive | 0.15 | Her2 | African | TCGA.AC.A3W5.01A.11R.A22K.07 |
| TCGA-AC-A62Y | 79 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.15 | LumA | European | TCGA.AC.A62Y.01A.11R.A29R.07 |
| TCGA-C8-A132 | 56 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | not evaluated | NA | NA | alive | 0.16 | LumA | East Asian | TCGA.C8.A132.01A.31R.A115.07 |
| TCGA-OL-A66P | 75 | female | Black or African American | Primary solid Tumor | not available | IDC | negative | negative | not evaluated | NA | NA | alive | 0.16 | Her2 | African | TCGA.OL.A66P.01A.11R.A31O.07 |
| TCGA-E9-A248 | 51 | female | White | Primary solid Tumor | perimenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.16 | Her2 | European | TCGA.E9.A248.01A.11R.A169.07 |
| TCGA-BH-A18G | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.17 | Basal | European | TCGA.BH.A18G.01A.11R.A12D.07 |
| TCGA-D8-A142 | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 0.17 | Basal | European | TCGA.D8.A142.01A.11R.A115.07 |
| TCGA-AC-A5EH | 76 | female | Black or African American | Primary solid Tumor | not available | IDC | positive | negative | negative | NA | NA | alive | 0.17 | Her2 | African_admix | TCGA.AC.A5EH.01A.11R.A28M.07 |
| TCGA-E9-A1R3 | 70 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.18 | LumA | European | TCGA.E9.A1R3.01A.31R.A14M.07 |
| TCGA-OK-A5Q2 | 59 | female | not available | Primary solid Tumor | unknown | ILC | positive | positive | negative | NA | NA | alive | 0.18 | LumA | African | TCGA.OK.A5Q2.01A.11R.A27Q.07 |
| TCGA-A7-A26J | 49 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.19 | LumA | European | TCGA.A7.A26J.01A.11R.A169.07 |
| TCGA-C8-A131 | 82 | female | Asian | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.19 | Basal | East Asian | TCGA.C8.A131.01A.11R.A115.07 |
| TCGA-AC-A8OS | 71 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.19 | LumA | European | TCGA.AC.A8OS.01A.12R.A41B.07 |
| TCGA-C8-A1HM | 74 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.19 | LumB | East Asian | TCGA.C8.A1HM.01A.12R.A137.07 |
| TCGA-AC-A23E | 50 | female | White | Primary solid Tumor | not available | IDC | positive | positive | not evaluated | NA | NA | alive | 0.2 | LumA | European | TCGA.AC.A23E.01A.11R.A157.07 |
| TCGA-BH-A0HL | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.2 | NA | European | TCGA.BH.A0HL.01A.11R.A10U.07 |
| TCGA-D8-A1Y2 | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | Indeterminate | NA | NA | alive | 0.2 | LumB | European | TCGA.D8.A1Y2.01A.11R.A157.07 |
| TCGA-D8-A27V | 62 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.2 | LumA | European | TCGA.D8.A27V.01A.12R.A17B.07 |
| TCGA-AC-A7VB | 51 | female | Black or African American | Primary solid Tumor | unknown | IDC | positive | negative | not evaluated | NA | NA | alive | 0.2 | LumB | African_admix | TCGA.AC.A7VB.01A.11R.A352.07 |
| TCGA-A7-A3J1 | 63 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.21 | NA | European | TCGA.A7.A3J1.01A.11R.A213.07 |
| TCGA-D8-A1XG | 86 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.21 | LumA | European | TCGA.D8.A1XG.01A.11R.A14D.07 |
| TCGA-A7-A3J0 | 62 | female | White | Primary solid Tumor | postmenopausal | mucinous carcinoma | positive | positive | negative | NA | NA | alive | 0.21 | NA | European | TCGA.A7.A3J0.01A.11R.A213.07 |
| TCGA-BH-A0HO | 48 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.21 | LumA | European | TCGA.BH.A0HO.01A.11R.A034.07 |
| TCGA-AQ-A54N | 51 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | equivocal | NA | NA | alive | 0.21 | NA | African | TCGA.AQ.A54N.01A.11R.A266.07 |
| TCGA-BH-A0DS | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.21 | LumA | European | TCGA.BH.A0DS.01A.11R.A056.07 |
| TCGA-HN-A2NL | 56 | female | not available | Primary solid Tumor | postmenopausal | ILC | negative | negative | negative | NA | NA | alive | 0.22 | Basal | European | TCGA.HN.A2NL.01A.11R.A18M.07 |
| TCGA-LL-A6FQ | 77 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.22 | LumA | African | TCGA.LL.A6FQ.01A.11R.A31O.07 |
| TCGA-D8-A1XY | 74 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.22 | LumA | European | TCGA.D8.A1XY.01A.11R.A14M.07 |
| TCGA-AR-A24P | 47 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.23 | LumA | European | TCGA.AR.A24P.01A.11R.A169.07 |
| TCGA-E9-A1R6 | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.23 | LumA | European | TCGA.E9.A1R6.01A.11R.A14D.07 |
| TCGA-D8-A1X7 | 40 | female | White | Primary solid Tumor | premenopausal | ductal partially papillary | positive | positive | negative | NA | NA | alive | 0.23 | NA | European | TCGA.D8.A1X7.01A.11R.A14M.07 |
| TCGA-MS-A51U | 44 | female | White | Primary solid Tumor | not available | ILC | positive | positive | negative | NA | NA | alive | 0.23 | NA | European | TCGA.MS.A51U.01A.31R.A266.07 |
| TCGA-AN-A04A | 36 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.25 | LumA | European | TCGA.AN.A04A.01A.21R.A034.07 |
| TCGA-E9-A6HE | 45 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.25 | LumA | European | TCGA.E9.A6HE.01A.11R.A31O.07 |
| TCGA-AC-A3TM | 50 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 0.25 | NA | European | TCGA.AC.A3TM.01A.11R.A22K.07 |
| TCGA-C8-A130 | 52 | female | Asian | Primary solid Tumor | perimenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.26 | LumB | East Asian | TCGA.C8.A130.01A.31R.A115.07 |
| TCGA-D8-A1JF | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.26 | Her2 | European | TCGA.D8.A1JF.01A.11R.A13Q.07 |
| TCGA-D8-A1XF | 45 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | LumB | European | TCGA.D8.A1XF.01A.11R.A14D.07 |
| TCGA-LL-A5YO | 50 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.27 | Her2 | African | TCGA.LL.A5YO.01A.21R.A28M.07 |
| TCGA-BH-A0DQ | 42 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | LumA | European | TCGA.BH.A0DQ.01A.11R.A084.07 |
| TCGA-BH-A0DQ | 42 | female | White | Solid Tissue Normal | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.27 | LumA | European | TCGA.BH.A0DQ.11A.12R.A089.07 |
| TCGA-BH-A5IZ | 51 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.27 | Basal | African | TCGA.BH.A5IZ.01A.11R.A27Q.07 |
| TCGA-LL-A7T0 | 70 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.27 | LumB | African | TCGA.LL.A7T0.01A.31R.A352.07 |
| TCGA-C8-A1HN | 56 | female | Asian | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.27 | LumB | East Asian | TCGA.C8.A1HN.01A.11R.A137.07 |
| TCGA-LL-A5YP | 49 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.27 | Basal | African | TCGA.LL.A5YP.01A.21R.A28M.07 |
| TCGA-BH-A0E0 | 38 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.37 | Basal | European | TCGA.BH.A0E0.01A.11R.A056.07 |
| TCGA-BH-A0E0 | 38 | female | White | Solid Tissue Normal | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.37 | Basal | European | TCGA.BH.A0E0.11A.13R.A089.07 |
| TCGA-BH-A6R9 | 61 | female | White | Primary solid Tumor | postmenopausal | metaplastic carcinoma | negative | positive | negative | NA | NA | alive | 0.44 | Normal | European | TCGA.BH.A6R9.01A.21R.A32P.07 |
| TCGA-AN-A0XV | 67 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.44 | LumA | European | TCGA.AN.A0XV.01A.11R.A109.07 |
| TCGA-AN-A0XL | 61 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.45 | LumA | European | TCGA.AN.A0XL.01A.11R.A10J.07 |
| TCGA-E2-A2P6 | 77 | female | not available | Primary solid Tumor | postmenopausal | ILC | positive | positive | not evaluated | NA | NA | alive | 0.46 | LumA | American | TCGA.E2.A2P6.01A.11R.A19W.07 |
| TCGA-AN-A0XW | 36 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.47 | LumA | European | TCGA.AN.A0XW.01A.11R.A109.07 |
| TCGA-BH-A0RX | 59 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.47 | Basal | European | TCGA.BH.A0RX.01A.21R.A084.07 |
| TCGA-AN-A0FF | 32 | female | White | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.47 | LumB | European | TCGA.AN.A0FF.01A.11R.A034.07 |
| TCGA-BH-A0HK | 81 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.49 | LumA | European | TCGA.BH.A0HK.01A.11R.A056.07 |
| TCGA-BH-A0HK | 81 | female | White | Solid Tissue Normal | postmenopausal | IDC | positive | negative | negative | NA | NA | alive | 0.49 | LumA | European | TCGA.BH.A0HK.11A.11R.A089.07 |
| TCGA-EW-A1PC | 66 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.51 | NA | African | TCGA.EW.A1PC.01B.11R.A21T.07 |
| TCGA-AN-A0FD | 71 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.54 | LumA | European | TCGA.AN.A0FD.01A.11R.A034.07 |
| TCGA-BH-A28Q | 46 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.54 | LumA | European | TCGA.BH.A28Q.01A.11R.A16F.07 |
| TCGA-AN-A0FS | 55 | female | White | Primary solid Tumor | perimenopausal | ILC | positive | negative | positive | NA | NA | alive | 0.57 | LumA | European | TCGA.AN.A0FS.01A.11R.A034.07 |
| TCGA-AN-A0FK | 88 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.58 | LumA | European | TCGA.AN.A0FK.01A.11R.A034.07 |
| TCGA-AN-A0FT | 63 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.59 | LumA | European | TCGA.AN.A0FT.01A.11R.A034.07 |
| TCGA-B6-A400 | 43 | female | Black or African American | Primary solid Tumor | unknown | IDC | negative | negative | negative | NA | NA | alive | 0.59 | NA | African | TCGA.B6.A400.01A.11R.A239.07 |
| TCGA-LD-A7W5 | 52 | female | Black or African American | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.59 | LumA | African | TCGA.LD.A7W5.01A.22R.A352.07 |
| TCGA-AN-A0FN | 61 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | positive | NA | NA | alive | 0.6 | LumA | European | TCGA.AN.A0FN.01A.11R.A034.07 |
| TCGA-BH-A18I | 53 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | positive | NA | NA | alive | 0.6 | LumA | European | TCGA.BH.A18I.01A.11R.A12D.07 |
| TCGA-A2-A4RW | 49 | female | White | Primary solid Tumor | premenopausal | ILC | positive | positive | negative | NA | NA | alive | 0.61 | NA | European | TCGA.A2.A4RW.01A.21R.A266.07 |
| TCGA-AN-A0AK | 76 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.61 | LumB | European | TCGA.AN.A0AK.01A.21R.A00Z.07 |
| TCGA-AR-A2LL | 70 | female | White | Primary solid Tumor | postmenopausal | ILC | positive | positive | equivocal | NA | NA | alive | 0.61 | NA | European | TCGA.AR.A2LL.01A.11R.A180.07 |
| TCGA-GI-A2C8 | 63 | female | White | Primary solid Tumor | not available | IDC | positive | positive | negative | NA | NA | alive | 0.62 | LumA | European | TCGA.GI.A2C8.01A.11R.A16F.07 |
| TCGA-GI-A2C8 | 63 | female | White | Solid Tissue Normal | not available | IDC | positive | positive | negative | NA | NA | alive | 0.62 | LumA | European | TCGA.GI.A2C8.11A.22R.A16F.07 |
| TCGA-AN-A0AL | 41 | female | White | Primary solid Tumor | premenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.62 | Basal | European | TCGA.AN.A0AL.01A.11R.A00Z.07 |
| TCGA-A7-A0CG | 78 | female | White | Primary solid Tumor | postmenopausal | ILC/IDC (grade 1) | positive | negative | negative | NA | NA | alive | 0.63 | NA | European | TCGA.A7.A0CG.01A.12R.A056.07 |
| TCGA-AN-A0FL | 62 | female | White | Primary solid Tumor | postmenopausal | IDC | negative | negative | positive | NA | NA | alive | 0.63 | Basal | European | TCGA.AN.A0FL.01A.11R.A034.07 |
| TCGA-A7-A0CH | 79 | female | White | Primary solid Tumor | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.64 | LumA | European | TCGA.A7.A0CH.01A.21R.A00Z.07 |
| TCGA-A7-A0CH | 79 | female | White | Solid Tissue Normal | postmenopausal | IDC | not evaluated | not evaluated | not evaluated | NA | NA | alive | 0.64 | LumA | European | TCGA.A7.A0CH.11A.32R.A089.07 |
| TCGA-A1-A0SM | 77 | male | White | Primary solid Tumor | not applicable | IDC | positive | negative | positive | NA | NA | alive | 0.66 | NA | European | TCGA.A1.A0SM.01A.11R.A084.07 |
| TCGA-AN-A0FJ | 59 | female | White | Primary solid Tumor | perimenopausal | IDC | positive | negative | positive | NA | NA | alive | 0.66 | Basal | European | TCGA.AN.A0FJ.01A.11R.A00Z.07 |
| TCGA-E2-A56Z | 69 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | positive | positive | equivocal | NA | NA | alive | 0.69 | LumB | African_admix | TCGA.E2.A56Z.01A.12R.A29R.07 |
| TCGA-EW-A1IY | 38 | female | Asian | Primary solid Tumor | premenopausal | IDC | positive | positive | negative | NA | NA | alive | 0.71 | LumB | East Asian | TCGA.EW.A1IY.01A.11R.A13Q.07 |
| TCGA-A1-A0SB | 70 | female | White | Primary solid Tumor | postmenopausal | adenoid cystic carcinoma | positive | negative | negative | NA | NA | alive | 0.71 | NA | European | TCGA.A1.A0SB.01A.11R.A144.07 |
| TCGA-A7-A6VY | 48 | female | Black or African American | Primary solid Tumor | postmenopausal | IDC | negative | negative | negative | NA | NA | alive | 0.73 | Basal | African_admix | TCGA.A7.A6VY.01A.12R.A33J.07 |
| TCGA-A7-A0DB | 56 | female | White | Primary solid Tumor | postmenopausal | IDC | positive | positive | negative | NA | NA | alive |